Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01475
|
|||||
| Drug Name |
Butyrate
|
|||||
| Synonyms |
butyric acid; butanoic acid; n-Butyric acid; 107-92-6; n-Butanoic acid; propylformic acid; ethylacetic acid; 1-propanecarboxylic acid; Butanic acid; butyrate; 1-Butyric acid; Buttersaeure; butanoate; Kyselina maselna; Butyric acid (natural); Propanecarboxylic acid; Buttersaeure [German]; 1-butanoic acid; FEMA Number 2221; Kyselina maselna [Czech]; FEMA No. 2221; CCRIS 6552; HSDB 940; butoic acid; Ethyacetic Acid; 2-butanoate; NSC 8415; UNII-40UIR9Q29H; UN2820; AI3-15306; EINECS 203-532-3; BRN 0906770; CH3-[CH2]2-COOH; 40UIR9Q29H
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Schizophrenia [ICD11: 6A20] | Phase 2/3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C4H7O2-
|
|||||
| Canonical SMILES |
CCCC(=O)[O-]
|
|||||
| InChI |
InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)/p-1
|
|||||
| InChIKey |
FERIUCNNQQJTOY-UHFFFAOYSA-M
|
|||||
| CAS Number |
CAS 461-55-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 87.1 | Topological Polar Surface Area | 40.1 | ||
| Heavy Atom Count | 6 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
1.4
|
|||||
| PubChem CID | ||||||
| PubChem SID |
3545
, 74110
, 584341
, 587668
, 639195
, 829106
, 841341
, 3132316
, 4802290
, 7849658
, 7886373
, 8137924
, 8145230
, 8150539
, 10318186
, 10503556
, 11120324
, 11120812
, 11121300
, 11405819
, 11447352
, 11528267
, 15363437
, 24424045
, 24438641
, 24851531
, 24891550
, 24900934
, 24900935
, 26711808
, 26715116
, 26746547
, 30339108
, 30388555
, 31062314
, 32452557
, 37374541
, 37388172
, 37904320
, 46393305
, 46505927
, 48414707
, 48417171
, 48423012
, 53787580
, 56464546
, 57320085
, 76464313
, 81062787
, 81064461
|
|||||
| ChEBI ID |
CHEBI:17968
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| MCT1 | Transporter Info | Monocarboxylate transporter 1 | Substrate | [3] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT03010865) Sodium Butyrate For Improving Cognitive Function In Schizophrenia | |||||
| 2 | The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein. Am J Physiol Cell Physiol. 2011 Nov;301(5):C984-94. | |||||
| 3 | Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid. AAPS J. 2008 Jun;10(2):311-21. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.